Aquis Exchange PLC Exercise of Share Options and Total Voting Rights (8221P)

TIDMAQX

RNS Number : 8221P

Aquis Exchange PLC

22 June 2022

22 June 2022

Aquis Exchange PLC

("Aquis" or the "Company")

Exercise of Share Options

and

Total Voting Rights

Aquis Exchange PLC (AQX.L, AQX.PL), the exchange services group, announces that it has received notification that an employee has exercised options under the Company's EMI Option Scheme over 1,333 ordinary shares of 10p each in the Company ("Ordinary Shares") at an exercise price of GBP3.55 per Ordinary Share.

Application has been made for 1,333 new Ordinary Shares to be admitted to trading on AQSE and AIM, which is expected to take place on 27 June 2022. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares in issue.

Total Voting Rights

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA, the Company confirms that, following this issue, its issued share capital will comprise 27,509,448 Ordinary Shares. All Ordinary Shares shall have equal voting rights and none of the Ordinary Shares are held in treasury. Accordingly, the figure of 27,509,448 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

 
 Aquis Exchange PLC                    Tel: [phone] 
 Richard Fisher, CFO 
 
 VSA Capital Limited (AQSE Corporate   Tel: [phone] 
  Adviser) 
 Andrew Raca 
 Pascal Wiese 
 
 Liberum Capital Limited (Nominated    Tel: [phone] 
  Adviser and Joint Broker) 
 Chris Clarke 
 Clayton Bush 
 Edward Thomas 
 Kane Collings 
 
 Canaccord Genuity Limited (Joint      Tel: [phone] 
  Broker) 
 Bobbie Hilliam 
 Patrick Dolaghan 
 
 Alma PR (Financial PR Adviser)        Tel: [phone] 
 Susie Hudson                          [e-mail] 
 Kieran Breheny 
 Matthew Young 
 

Notes to Editors

About Aquis Exchange

Aquis Exchange PLC is an exchange services group, which operates pan-European cash equities trading businesses (Aquis Exchange), growth and regulated primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange software to third parties (Aquis Technologies).

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK/Switzerland and in EU27 respectively. Aquis operates lit order books and does not allow aggressive non-client proprietary trading, which has resulted in lower market impact and signalling risk on Aquis than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEMZGZVMZRGZZM

(END) Dow Jones Newswires

June 22, 2022 07:30 ET (11:30 GMT)